Sami Farhad,Acharya Prakash,Noonan Grace,Maurides Steven,AlMasry Anas Abudan,Bajwa Suhaib,Parimi Nikhil,Boda Ilham,Tran Christina,Goyal Amandeep,Mastoris Ioannis,Dalia Tarun,Sauer Andrew,Van Bakel Adrian,Shah Zubair.Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine.[J].Journal of cardiac failure,2022.

Costa Ricardo Vivacqua Cardoso.NYHA Classification and Cardiopulmonary Exercise Test Variables in Patients with Heart Failure.[J].Arquivos brasileiros de cardiologia,2022.

Luigi Cappannoli,Roberto Scacciavillani,Erica Rocco,Francesco Perna,Maria Lucia Narducci,Marcello Vaccarella,Domenico D’Amario,Gemma Pelargonio,Massimo Massetti,Filippo Crea,Nadia Aspromonte.Cardiac contractility modulation for patient with refractory heart failure: an updated evidence-based review[J].Heart Failure Reviews,2020.

Zhang Xin,Hu Can,Kong Chun-Yan,Song Peng,Wu Hai-Ming,Xu Si-Chi,Yuan Yu-Pei,Deng Wei,Ma Zhen-Guo,Tang Qi-Zhu.FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.[J].Cell death and differentiation,2020.

陈新馨,林彩娜,冯敏.6min步行试验联合血清细胞因子对慢性心力衰竭患者预后的评估价值[J].中华老年多器官疾病杂志,2023(04).

吴传忠,黄观育,吴小玲.多巴酚丁胺联合米力农对顽固性心力衰竭的疗效及对心功能的影响[J].中国处方药,2022(12).

刘佳宝,张瑞英.心力衰竭时氧化应激与心肌代谢[J].国际心血管病杂志,2022(02).

高玉梅,李瀛均,耿文怡,孙晓洁.问题解决疗法对慢性心力衰竭患者心理状态及自护能力的影响[J].海南医学,2022(03).

王娴君.冻干重组人脑利钠肽联合福辛普利钠治疗顽固性心力衰竭的临床研究[J].现代药物与临床,2021(06).

廖翩,徐建辉,邱俊英.福辛普利钠联合比索洛尔、螺内酯对老年冠心病心力衰竭患者心功能、血脂代谢的影响[J].心血管康复医学杂志,2021(02).

马新豫.黄芪联合多巴酚丁胺及酚妥拉明治疗慢性肺源性心脏病顽固性心力衰竭疗效观察[J].新乡医学院学报,2021(02).

闵丽杰.米力农与多巴酚丁胺治疗顽固性心力衰竭患者的临床疗效比较[J].中国医药指南,2020(31).

杨志刚.福辛普利钠联合螺内酯片及呋塞米治疗顽固性心力衰竭患者的疗效分析[J].现代诊断与治疗,2020(18).

刘旭光,殷月玲.复方丹参片辅助治疗对老年心力衰竭患者炎症反应及氧化应激反应的干预效果[J].国际医药卫生导报,2020(18).

刘杲,伊争伟,张鹏博.左西孟旦联合托伐普坦对顽固性心力衰竭患者氧化应激心肌损伤及心功能的影响[J].安徽医学,2019(06).

程志祥,冯飞,覃辉.福辛普利钠联合环磷腺苷葡胺治疗慢性心力衰竭的临床研究[J].现代药物与临床,2018(10).

中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014(02).